Completed NA INTERVENTIONAL NCT01568853

A Prospective Study of The Complement Depletion in Patients With Severe Abdominal Sepsis

The Complement C3 Depletion in Patients With Severe Abdominal Sepsis: Risk Prediction and the Association With Down-regulated Adaptive Immunity

Sponsor: Jinling Hospital, China

Conditions Abdominal Abscess Appendicitis Digestive System Fistula Pancreatitis Severe Sepsis

Interventions Norepinephrine Open abdomen enteral nutrition parenteral nutrition

Updated 6 times since 2017 Last updated: Apr 5, 2012 Started: Nov 30, 2011 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Abdominal Abscess and Appendicitis and is currently completed. Jinling Hospital, China leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jinling Hospital, China

Data source: Jinling Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China